Godrej Agrovet

Has Godrej Agrovet declared dividend?

Yes, Godrej Agrovet Ltd. has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of July 26, 2024. The company has shown strong total returns over various periods, particularly a 121.72% total return over the past five years.

Godrej Agrovet Ltd. has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 26 Jul 24<BR><BR>Dividend Yield: 1.22%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 5.06%, with no dividend return, resulting in a total return of 5.06%.<BR><BR>Over the past year, the price return was 44.74%, with a dividend return of 1.70%, leading to a total return of 46.44%.<BR><BR>In the 2-year period, the price return was 85.38%, with a dividend return of 4.28%, culminating in a total return of 89.66%.<BR><BR>For the 3-year period, the price return was 56.22%, with a dividend return of 5.79%, resulting in a total return of 62.01%.<BR><BR>In the last 4 years, the price return was 43.42%, with a dividend return of 6.11%, leading to a total return of 49.53%.<BR><BR>Over the past 5 years, the price return was 111.95%, with a dividend return of 9.77%, culminating in a total return of 121.72%.<BR><BR>Overall, Godrej Agrovet has declared a significant dividend, and the total returns across various periods indicate strong performance, particularly over the longer term, with notable price appreciation and increasing dividend contributions.

Who are the peers of the Godrej Agrovet?

Godrej Agrovet's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., and others, with varying management risks and capital structures. Godrej Agrovet leads in 1-year returns at 50.65%, while most peers show below-average growth and some have negative returns.

Peers: The peers of Godrej Agrovet are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Bombay Burmah, Jyothy Labs, Zydus Wellness, CCL Products, and Avanti Feeds.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., while Good management risk is found at Hind. Unilever, Godrej Consumer, Jyothy Labs, CCL Products, and Avanti Feeds, and Average management risk is noted at Bombay Burmah and Zydus Wellness. All peers exhibit Below Average growth except for Nestle India, which has Average growth. Capital Structure ratings are Excellent for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Bombay Burmah, Jyothy Labs, Zydus Wellness, and Avanti Feeds, while Godrej Agrovet and CCL Products have Average capital structure.<BR><BR>Return Snapshot: Godrej Agrovet has the highest 1-year return at 50.65%, while Jyothy Labs has the lowest at -13.07%. Compared to its peers, Godrej Agrovet's return is significantly higher. Additionally, Bombay Burmah, Jyothy Labs, and Zydus Wellness have negative six-month returns.

Who are in the management team of Godrej Agrovet?

As of March 2023, the management team of Godrej Agrovet includes N B Godrej (Chairman), Balram Singh Yadav (Managing Director), and several non-executive and independent directors, totaling 15 members who guide the company's governance and strategy.

As of March 2023, the management team of Godrej Agrovet includes the following individuals:<BR><BR>1. N B Godrej - Chairman (Non-Executive)<BR>2. Jamshyd N Godrej - Non-Executive & Non-Independent Director<BR>3. Tanya Arvind Dubash - Non-Executive & Non-Independent Director<BR>4. Nisaba Godrej - Non-Executive & Non-Independent Director<BR>5. Balram Singh Yadav - Managing Director<BR>6. Roopa Purushothaman - Independent Director<BR>7. Aditi Kothari Desai - Independent Director<BR>8. Ritu Niraj Anand - Independent Director<BR>9. Vivek Raizada - Company Secretary & Compliance Officer<BR>10. Pirojsha Godrej - Non-Executive & Non-Independent Director<BR>11. Natarajan Srinivasan - Independent Director<BR>12. Kannan Sitaram - Independent Director<BR>13. Ashok Gulati - Independent Director<BR>14. Burjis Godrej - Executive Director<BR>15. Ritu Verma - Independent Director<BR><BR>This diverse team includes a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

What does Godrej Agrovet do?

Godrej Agrovet Ltd. is a mid-cap company in the FMCG sector, incorporated in 1991, with recent quarterly net sales of ₹21,336 Cr and net profit of ₹708 Cr. Key metrics include a P/E ratio of 35.00, a dividend yield of 1.29%, and a market cap of ₹15,026 Cr.

Overview:<BR>Godrej Agrovet Ltd. operates in the FMCG industry and is classified as a mid-cap company.<BR><BR>History:<BR>Godrej Agrovet Limited was incorporated in 1991 as a private limited company and became a deemed public limited company in 1992. It was converted into a public limited company in 2002. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 21,336 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 708 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 15,026 Cr (Mid Cap) <BR><BR>Key Metrics:<BR>P/E: 35.00 <BR>Industry P/E: 56 <BR>Dividend Yield: 1.29% <BR>Debt Equity: 0.57 <BR>Return on Equity: 18.05% <BR>Price to Book: 6.28 <BR><BR>Contact Details:<BR>Address: 3rd Flr Pirojshanagar, Eastern Exp Highway Vikhroli(E Mumbai Maharashtra : 400079 <BR>Tel: 91-22-25194416 <BR>Email: gavlinvestors@godrejagrovet.com <BR>Website: http://www.godrejagrovet.com

Who are the top shareholders of the Godrej Agrovet?

The top shareholders of Godrej Agrovet include Godrej Industries Limited with 64.87%, mutual funds with 3.15%, 76 foreign institutional investors holding 3.77%, and individual investors owning 10.45%. The highest public shareholder is V-sciences Investments Pte Ltd., also at 3.77%.

The top shareholders of Godrej Agrovet are primarily the promoters, with Godrej Industries Limited holding the largest stake at 64.87%. There are also mutual funds involved, with 18 schemes collectively holding 3.15% of the shares. Additionally, 76 foreign institutional investors (FIIs) hold 3.77%. The highest public shareholder is V-sciences Investments Pte Ltd., which also holds 3.77%. Individual investors collectively own 10.45% of the company.

How big is Godrej Agrovet?

As of 24th July, Godrej Agrovet Ltd. has a market capitalization of 16,323.00 Cr, with recent net sales of 9,382.77 Cr and a net profit of 429.72 Cr.

As of 24th July, Godrej Agrovet Ltd. has a market capitalization of 16,323.00 Cr and is classified as a Mid Cap company.<BR><BR>In the latest four quarters, Godrej Agrovet reported Net Sales of 9,382.77 Cr and a Net Profit of 429.72 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,380.90 Cr and Total Assets of 5,505.49 Cr.

When is the next results date for Godrej Agrovet?

The next results date for Godrej Agrovet is August 6, 2025.

The next results date for Godrej Agrovet is scheduled for August 6, 2025.

Is Godrej Agrovet technically bullish or bearish?

As of October 8, 2025, Godrej Agrovet's technical trend has shifted to a bearish stance, supported by bearish indicators such as MACD, Bollinger Bands, and moving averages, along with a notable decline relative to the Sensex.

As of 8 October 2025, the technical trend for Godrej Agrovet has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is bearish weekly and mildly bearish monthly, while Dow Theory indicates a mildly bearish trend on the weekly and monthly charts. The stock's recent performance shows a significant decline compared to the Sensex, further supporting the bearish outlook.

How has been the historical performance of Godrej Agrovet?

Godrej Agrovet has shown steady growth in net sales and profits, with net sales at 9,382.77 Cr in March 2025, an increase in operating profit to 859.68 Cr, and improved cash flow from operating activities to 969.00 Cr. Overall, the company has demonstrated resilience and growth in its financial performance.

Answer:<BR>The historical performance of Godrej Agrovet shows a steady growth trajectory in net sales and profit metrics over the years.<BR><BR>Breakdown:<BR>Godrej Agrovet's net sales reached 9,382.77 Cr in March 2025, a slight decrease from 9,560.55 Cr in March 2024 but an increase from 9,373.68 Cr in March 2023. The total operating income followed a similar trend, with figures of 9,382.77 Cr in March 2025, 9,560.55 Cr in March 2024, and 9,373.68 Cr in March 2023. The company's operating profit (PBDIT) increased to 859.68 Cr in March 2025 from 742.77 Cr in March 2024, indicating improved operational efficiency. Profit before tax also rose to 500.23 Cr in March 2025 from 420.61 Cr in March 2024, while profit after tax increased to 349.80 Cr from 307.41 Cr in the same period. The total assets of Godrej Agrovet stood at 5,505.49 Cr in March 2025, down from 5,666.57 Cr in March 2024, while total liabilities decreased to 5,505.49 Cr from 5,666.57 Cr. The cash flow from operating activities improved significantly to 969.00 Cr in March 2025, compared to 678.00 Cr in March 2024, reflecting stronger cash generation capabilities. Overall, Godrej Agrovet has demonstrated resilience and growth in its financial performance over the years.

Is Godrej Agrovet overvalued or undervalued?

As of November 6, 2025, Godrej Agrovet is considered fairly valued with a PE ratio of 27.37 and an attractive valuation compared to peers like Hindustan Unilever and Nestle India, despite a year-to-date stock decline of 16.36% against the Sensex's gain of 6.62%.

As of 6 November 2025, the valuation grade for Godrej Agrovet has moved from very attractive to attractive, indicating a shift in market perception. The company is currently considered fairly valued. Key ratios include a PE ratio of 27.37, an EV to EBITDA of 15.62, and a ROE of 18.05%. <BR><BR>In comparison to its peers, Godrej Agrovet's valuation appears more reasonable, especially when contrasted with Hindustan Unilever's PE ratio of 54.11 and Nestle India's PE ratio of 81.85, both of which are categorized as very expensive. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 16.36% compared to the Sensex's gain of 6.62%, the company's fundamentals suggest it is positioned well within its sector.

Are Godrej Agrovet Ltd. latest results good or bad?

Godrej Agrovet Ltd.'s latest Q3 FY26 results show strong revenue growth and a net profit increase, but profitability is under pressure with declining operating margins and rising debt levels. Overall, the results are mixed, indicating positive recovery but caution is warranted due to underlying challenges.

Godrej Agrovet Ltd.'s latest results for Q3 FY26 present a mixed picture. On the positive side, the company reported a net profit of ₹114.82 crores, which is a significant sequential increase of 24.01% from the previous quarter and a slight year-on-year increase of 2.99%. Additionally, revenue reached ₹2,718.32 crores, marking a robust growth of 5.88% quarter-on-quarter and 10.97% year-on-year, indicating strong demand in their animal nutrition and crop protection segments.<BR><BR>However, there are notable concerns regarding profitability. The operating margin for the quarter was 8.90%, which, while showing a slight improvement from the previous quarter, is down 10 basis points compared to the same quarter last year. This suggests that the company is facing cost pressures that it has struggled to fully pass on to customers, leading to margin compression despite revenue growth.<BR><BR>Furthermore, the company's debt-to-equity ratio has risen to 1.19 times, the highest in recent quarters, raising concerns about financial flexibility and risk management. The return on equity remains strong at 17.51%, but the overall financial trend has been flat, indicating challenges in sustaining growth and profitability.<BR><BR>In summary, while Godrej Agrovet has shown strong revenue growth and a recovery in net profit, the ongoing margin pressures and elevated leverage present significant challenges. Therefore, the results can be viewed as good in terms of revenue and profit recovery, but the underlying issues suggest caution moving forward.

Should I buy, sell or hold Godrej Agrovet Ltd.?

Why is Godrej Agrovet Ltd. falling/rising?

As of 07-Feb, Godrej Agrovet Ltd. is facing a decline in stock price, currently at 552.00, with a recent drop in investor participation and poor long-term growth metrics. Despite an attractive valuation, negative sentiment persists due to underperformance and high debt levels.

As of 07-Feb, Godrej Agrovet Ltd. is experiencing a decline in its stock price, currently at 552.00, reflecting a change of -2.4 (-0.43%). The stock has been underperforming, particularly in the short term, as it has fallen for the last two consecutive days, resulting in a total decline of -1.23% during this period. Additionally, the stock's performance today has underperformed its sector by -1.83%.<BR><BR>Investor participation has also decreased, with delivery volume dropping by -39.32% compared to the 5-day average, indicating a lack of interest from investors. This decline in participation is further emphasized by the fact that institutional investors have reduced their stake by -0.71% over the previous quarter, which may signal a lack of confidence in the stock's future performance.<BR><BR>In terms of long-term growth, Godrej Agrovet has shown poor results, with net sales growing at an annual rate of only 9.30% and operating profit at 8.69% over the last five years. The stock has generated a significant return of -27.76% over the past year, which is considerably worse than the benchmark Sensex, which has increased by 7.07% during the same period. This underperformance in both the long term and near term contributes to the negative sentiment surrounding the stock.<BR><BR>While the company has an attractive valuation with a return on capital employed (ROCE) of 15.7 and is trading at a discount compared to its peers, the overall market perception remains cautious due to the flat results reported in December and a high debt-equity ratio of 1.19 times. These factors collectively contribute to the downward pressure on Godrej Agrovet's stock price.

Which are the latest news on Godrej Agrovet?